Form 4: UnitedHealth Group Director Kristen Gil Reports Stock Acquisitions

Director Kristen Gil reports acquisition of UnitedHealth Group common stock and deferred stock units as part of quarterly compensation.

Summary

• Kristen Gil, a director of UnitedHealth Group, reported the acquisition of common stock and deferred stock units on April 1, 2024.
• The acquisitions were part of regular quarterly compensation for service as a director.
• 115 deferred stock units were acquired at a price of $0.
• 64 shares of common stock were acquired at a price of $0.
• The director also holds 110 shares indirectly through a trust.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating stability and alignment of interests. It's a neutral to slightly positive signal.

Positives

• The acquisition of stock demonstrates the director's continued investment in the company's success.
• Deferred stock units align the director's interests with the long-term performance of the company.

Industry Context

Director compensation in the form of stock and deferred stock units is a common practice in publicly traded companies to align the interests of board members with those of shareholders.

Comparison to Industry Standards

• Stock grants to board members are a common practice among large publicly traded companies such as UnitedHealth Group.
• Companies like Johnson & Johnson, Pfizer, and Merck also provide stock-based compensation to their directors.
• The specific amount and type of equity compensation can vary based on company size, performance, and industry standards.

Stakeholder Impact

• The stock acquisition by a director can positively influence shareholder confidence.
• It demonstrates the director's commitment to the company's long-term success.

Key Dates